Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| CLIK | PRESS-RELEASE | mixed | 5/10 | Click Holdings announced a strategic MOU to acquire a 15% stake in Flash Mutual Technology for US$0.64 million, marking | Apr 28, 2026 |
| ITRI | PRESS-RELEASE | mixed | 6/10 | Itron reported Q1 2026 non-GAAP diluted EPS of $1.49, beating the $1.24 consensus by 20.2%, but total revenue of $587M d | Apr 28, 2026 |
| ARTL | PRESS-RELEASE | neutral | 3/10 | Artelo Biosciences announced a strategic partnership with AI company ScienceMachine to accelerate development of its FAB | Apr 28, 2026 |
| EBS | PRESS-RELEASE | neutral | 4/10 | Emergent BioSolutions announced a ~$34.5M agreement with Substipharm Biologics to manufacture drug substance for the IMO | Apr 28, 2026 |
| RVSB | PRESS-RELEASE | bearish | 7/10 | Riverview Bancorp reported a GAAP net loss of $8.0M ($0.39/share) for FQ4 2026 due to an $11.4M pre-tax loss from a stra | Apr 28, 2026 |
| ASML | PRESS-RELEASE | neutral | 2/10 | ASML disclosed its ongoing share buyback program transactions, a routine capital return activity. The press release prov | Apr 28, 2026 |
| CBC | PRESS-RELEASE | bullish | 7/10 | Central Bancompany reported Q1 2026 GAAP EPS of $0.46, beating the $0.43 consensus by 7.0%, with net income of $111.1M u | Apr 28, 2026 |
| AUBN | PRESS-RELEASE | bullish | 6/10 | Auburn National Bancorporation reported Q1 2026 EPS of $0.63, up 43% YoY from $0.44, and net earnings of $2.2M vs $1.5M | Apr 28, 2026 |
| NAUT | PRESS-RELEASE | neutral | 4/10 | Nautilus Biotechnology reported Q1 2026 EPS of -$0.12, beating consensus of -$0.14 by 17.2%, with revenue still at $0 as | Apr 28, 2026 |
| FELE | PRESS-RELEASE | neutral | 5/10 | Franklin Electric reported Q1 2026 revenue of $500.4M, 10% YoY growth and 4.4% above consensus, while GAAP EPS of $0.77 | Apr 28, 2026 |
| LEGN | PRESS-RELEASE | neutral | 1/10 | Legend Biotech USA Inc. announced it will host a conference call on May 12, 2026 to discuss its Q1 2026 results. | Apr 28, 2026 |
| PRFX | PRESS-RELEASE | neutral | 4/10 | PRF Technologies announced FDA clearance of its IND application for OcuRing™-K, a sustained-release intraocular ring for | Apr 28, 2026 |
| WSO | PRESS-RELEASE | mixed | 5/10 | Watsco reported flat Q1 2026 revenues ($1.53B) with a 3% decline in EPS to $1.87 and 2% decline in operating income. Sep | Apr 28, 2026 |
| CYTK | PRESS-RELEASE | neutral | 3/10 | Cytokinetics announced nine presentations at the ESC Heart Failure 2026 Congress, including a late-breaking oral present | Apr 28, 2026 |
| SLG | PRESS-RELEASE | neutral | 3/10 | SL Green Realty Corp. announced it secured the asset management assignment to lease 15 Laight Street, a 109,000 sq ft bo | Apr 28, 2026 |
| WVE | PRESS-RELEASE | bullish | 7/10 | Wave Life Sciences reported Q1 2026 revenue of $38.2M (vs consensus $7.9M) and EPS of -$0.13 (vs consensus -$0.31), repr | Apr 28, 2026 |
| PSTV | PRESS-RELEASE | neutral | 3/10 | Plus Therapeutics subsidiary CNSide Diagnostics secured a new payer coverage agreement with Blue Shield of California, e | Apr 28, 2026 |
| KNSA | PRESS-RELEASE | bullish | 8/10 | Kiniksa reported Q1 2026 revenue of $214.3M (56% YoY growth) and GAAP diluted EPS of $0.27, beating consensus EPS of $0. | Apr 28, 2026 |
| EXOD | PRESS-RELEASE | bullish | 7/10 | Exodus has appointed receivers over three subsidiaries of W3C Corp after W3C defaulted on a $70 million secured loan. Th | Apr 28, 2026 |
| JFIN | PRESS-RELEASE | neutral | 2/10 | Jiayin Group filed its annual report on Form 20-F for FY2025, a routine regulatory filing with no new financial disclosu | Apr 28, 2026 |
| MSC | PRESS-RELEASE | neutral | 1/10 | Studio City announced it will report its Q1 2026 results on April 30, 2026. | Apr 28, 2026 |
| MLCO | PRESS-RELEASE | neutral | 1/10 | Melco Resorts & Entertainment Limited announced it will report its Q1 2026 results on April 30, 2026. | Apr 28, 2026 |
| BNR | PRESS-RELEASE | neutral | 2/10 | Burning Rock Biotech filed its 2025 annual report (Form 20-F) with the SEC, a routine regulatory requirement. The press | Apr 28, 2026 |
| DCO | PRESS-RELEASE | neutral | 1/10 | Ducommun Incorporated announced it will host a conference call on May 12, 2026 to discuss its Q1 results. | Apr 28, 2026 |
| ACRS | PRESS-RELEASE | bullish | 7/10 | Aclaris reported positive full Phase 1a results for ATI-052, an anti-TSLP/IL-4Rα bispecific antibody, showing a 45-day h | Apr 28, 2026 |
| TRU | PRESS-RELEASE | bullish | 6/10 | TransUnion reported Q1 2026 revenue of $1.246B (+14% YoY), beating consensus of $1.22B, and adjusted EPS of $1.18, beati | Apr 28, 2026 |
| B | PRESS-RELEASE | mixed | 6/10 | Barrick Mining announced the planned IPO of a minority stake in a new company holding its North American gold assets (Ne | Apr 28, 2026 |
| EUDA | PRESS-RELEASE | neutral | 3/10 | EUDA Health announced that its partner Shenzhen Inno Immune received government approval for a TCR-T cell therapy R&D pr | Apr 28, 2026 |
| RDNT | PRESS-RELEASE | neutral | 1/10 | RadNet, Inc. announced it will report its Q1 2026 results on May 11, 2026. | Apr 28, 2026 |
| JD | PRESS-RELEASE | neutral | 1/10 | JD.com, Inc. announced it will report its Q1 2026 results on May 12, 2026. | Apr 28, 2026 |
« Previous Page 334 of 334